{
    "clinical_study": {
        "@rank": "73896", 
        "arm_group": {
            "arm_group_label": "Physician Readers", 
            "arm_group_type": "Experimental", 
            "description": "Physician readers will interpret Amyvid scans using qualitative analysis followed by the use of quantitation. No subjects will be exposed to Florbetapir F 18 as part of this study."
        }, 
        "brief_summary": {
            "textblock": "The overall objective of the study is to assess the feasibility of implementing a\n      quantitative process of florbetapir F 18 scan interpretation. The hypothesis is that the use\n      of quantitative analysis will increase the accuracy of florbetapir F 18 scan interpretation."
        }, 
        "brief_title": "The Feasibility of Florbetapir Quantitation", 
        "completion_date": {
            "#text": "January 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Alzheimers Disease", 
        "condition_browse": {
            "mesh_term": "Alzheimer Disease"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Readers have undergone Amyvid reader training\n\n          -  Readers have minimal experience with quantitation of amyloid PET scans\n\n        Exclusion Criteria:\n\n          -  Readers have previously been trained to quantitate amyloid PET scans"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A"
        }, 
        "enrollment": {
            "#text": "96", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 17, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01946243", 
            "org_study_id": "18F-AV-45-QP01"
        }, 
        "intervention": {
            "arm_group_label": "Physician Readers", 
            "description": "No Florbetapir F 18 will be administered in this study.", 
            "intervention_name": "Florbetapir F18", 
            "intervention_type": "Drug", 
            "other_name": [
                "Amyvid", 
                "18F-AV-45", 
                "florbetapir"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "lastchanged_date": "November 21, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Philadelphia", 
                    "country": "United States", 
                    "state": "Pennsylvania", 
                    "zip": "19103"
                }, 
                "name": "Research Site"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "overall_contact": {
            "email": "clinicaloperations@avidrp.com", 
            "last_name": "Avid Clinical Operations", 
            "phone": "215-298-0700"
        }, 
        "overall_official": {
            "affiliation": "Avid Radiopharmaceuticals, Inc.", 
            "last_name": "Chief Medical Officer", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "January 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Evaluate whether the use of quantitation software improves the total accuracy of florbetapir F 18 scan interpretation. Total accuracy is defined as the number of scans correctly interpreted (vs. a truth standard) divided by the total number of scans read.", 
            "measure": "Change in reader accuracy after application of quantitation software", 
            "safety_issue": "No", 
            "time_frame": "Scan acquired 50-60 min post injection"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01946243"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Evaluate whether the use of quantitation software improves the reliability of florbetapir F 18 scan interpretation. The scan interpretation reliability will be evaluated using Fleiss' Kappa statistics.", 
            "measure": "Change in scan interpretation reliability after application of quantitation software", 
            "safety_issue": "No", 
            "time_frame": "Scan acquired 50-60 min post injection"
        }, 
        "source": "Avid Radiopharmaceuticals", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Avid Radiopharmaceuticals", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "August 2013", 
        "study_design": "Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Diagnostic", 
        "study_type": "Interventional", 
        "verification_date": "November 2013"
    }
}